Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of body composition in diverticular disease.
Freckelton J, Holt D, Borsaru A, Gwini S, Croagh D, Moore G. Freckelton J, et al. Int J Colorectal Dis. 2018 Sep;33(9):1299-1302. doi: 10.1007/s00384-018-3058-y. Epub 2018 Apr 18. Int J Colorectal Dis. 2018. PMID: 29671060
Accuracy of ultrasound, bioelectrical impedance analysis and anthropometry as point-of-care measurements of skeletal muscle mass in patients with inflammatory bowel disease.
Nguyen AL, Burns M, Herath M, Lambell K, Holt D, Fitzpatrick J, Milat F, Ebeling PR, Gibson PR, Moore GT. Nguyen AL, et al. Among authors: moore gt. Aliment Pharmacol Ther. 2023 Aug;58(3):309-321. doi: 10.1111/apt.17607. Epub 2023 Jun 12. Aliment Pharmacol Ther. 2023. PMID: 37305984 Free PMC article.
Thiopurine metabolite testing in inflammatory bowel disease.
Goldberg R, Moore G, Cunningham G, Schulberg J, Marsh P, Brown S, Connell W, Lust M, Kamm MA, Bell S. Goldberg R, et al. J Gastroenterol Hepatol. 2016 Mar;31(3):553-60. doi: 10.1111/jgh.13210. J Gastroenterol Hepatol. 2016. PMID: 26510636
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR; GALAXI-1 Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):133-146. doi: 10.1016/S2468-1253(23)00318-7. Epub 2023 Dec 14. Lancet Gastroenterol Hepatol. 2024. PMID: 38104569 Clinical Trial.
140 results